Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Levothyroxine sodium
Medication labelHypothyroidism Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as a replacement therapy in…
Why this: Advisory · dailymed-prescription
Hypothyroidism Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use Levothyroxine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with levothyroxine sodium tablets may induce hyperthyroidism [see Warnings and Precautions (5.1)]. Levothyroxine sodium tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis.
- generic_name
- levothyroxine sodium
- product_names
- LEVOTHYROXINE SODIUM
- ndc
- 33342-393, 33342-394, 33342-395, 33342-396, 33342-397, 33342-398, 33342-399, 33342-400, 33342-401, 33342-402, 33342-403, 33342-404, 33342-393-10, 33342-393-11, 33342-393-44, 33342-394-10, 33342-394-11, 33342-394-44, 33342-395-10, 33342-395-11, 33342-395-44, 33342-396-10, 33342-396-11, 33342-396-44, 33342-397-10, 33342-397-11, 33342-397-44, 33342-398-10, 33342-398-11, 33342-398-44, 33342-399-10, 33342-399-11, 33342-399-44, 33342-400-10, 33342-400-11, 33342-400-44, 33342-401-10, 33342-401-11, 33342-401-44, 33342-402-10, 33342-402-11, 33342-402-44, 33342-403-10, 33342-403-11, 33342-403-44, 33342-404-10, 33342-404-11, 33342-404-44
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en